Use and misuse of buprenorphine in the management of opioid addiction.
about
Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database.Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.Consumer attitudes about opioid addiction treatment: a focus group study in New York City.Buprenorphine for opioid dependenceA review of buprenorphine diversion and misuse: the current evidence base and experiences from around the world.Toward a systematic approach to opioid rotation.Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trialOpioids and the treatment of chronic pain: controversies, current status, and future directions.Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.Illicit use of buprenorphine in a community sample of young adult non-medical users of pharmaceutical opioids.Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention.Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine.Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes.The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.Clinician beliefs and attitudes about buprenorphine/naloxone diversionMethadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.The New Kid on the Block--Incorporating Buprenorphine into a Medical Toxicology Practice.Buprenorphine treatment for narcotic addiction: not without risks.Opioid substitution therapy for dependent health care practitioners: approach with cautionMySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
P2860
Q33429402-1E4FAA31-494E-4FA3-BA06-E2506E1F20ACQ33576948-530D9307-EEAC-4FDF-ABB2-AB892AF0F516Q33576957-90820CF6-BA07-454A-89F5-EF66A36993B4Q34119459-01D1C96F-D493-4D0C-8900-CE5ED5C1A1E9Q34253036-D86412E9-C0B1-4810-B6A0-542A3E0CF7E8Q34394425-2AE395C1-02C4-456E-A703-675F82750E08Q34598914-88BC14C1-C0E9-4643-B36A-6D0B5BC29716Q34846394-F52B3B57-FC9A-4610-918B-FB0EF8CB7BEBQ35167576-684C5634-9A4A-4902-9124-D0A737AF808DQ35800468-D866FD35-680D-4A3A-8E69-43073E6AB211Q36030969-A0F2C3C8-194D-48F0-B7A3-F51A1CC2D9CBQ36253355-755897AF-A37B-4BA0-96CB-A79D30E3D066Q37079839-C13B870D-CD9B-4FA3-801E-EB1EADB3B102Q37180966-3B6D3A5F-CE72-458E-9604-540118555F21Q37241381-6B5F3F1C-7000-49DD-A098-6897356D3B0CQ37282456-F5A7AF36-1C4B-44EC-8135-801A8EAA6A49Q38634946-A469A7ED-CDB0-4766-9804-362AA80668B7Q40283005-04285BC0-AA20-45F4-AAA4-DB7B9F2CA015Q42336473-78EC3309-9FF2-4F58-B9E7-F71BE845D57CQ58700874-C48AEF49-4A29-41EF-98DA-2929A367E554
P2860
Use and misuse of buprenorphine in the management of opioid addiction.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Use and misuse of buprenorphine in the management of opioid addiction.
@en
Use and misuse of buprenorphine in the management of opioid addiction.
@nl
type
label
Use and misuse of buprenorphine in the management of opioid addiction.
@en
Use and misuse of buprenorphine in the management of opioid addiction.
@nl
prefLabel
Use and misuse of buprenorphine in the management of opioid addiction.
@en
Use and misuse of buprenorphine in the management of opioid addiction.
@nl
P2093
P1476
Use and misuse of buprenorphine in the management of opioid addiction.
@en
P2093
Hilary L Surratt
James Inciardi
Theodore J Cicero
P304
P577
2007-11-01T00:00:00Z